Robert W. Baird Raises Intuitive Surgical (NASDAQ:ISRG) Price Target to $503.00

Intuitive Surgical (NASDAQ:ISRG) had its target price raised by Robert W. Baird from $487.00 to $503.00 in a report published on Friday morning, Benzinga reports. Robert W. Baird currently has an outperform rating on the medical equipment provider’s stock.

Several other brokerages have also recently issued reports on ISRG. Piper Sandler raised their target price on Intuitive Surgical from $435.00 to $490.00 and gave the stock an overweight rating in a research report on Tuesday, July 9th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a hold rating in a report on Friday, April 19th. Barclays lifted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an overweight rating in a research note on Thursday. Stifel Nicolaus upped their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a buy rating in a research note on Monday, April 8th. Finally, Truist Financial lifted their target price on Intuitive Surgical from $450.00 to $515.00 and gave the company a buy rating in a research report on Tuesday, July 16th. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average price target of $438.74.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $455.01 on Friday. The stock has a market cap of $161.39 billion, a price-to-earnings ratio of 82.13, a PEG ratio of 5.87 and a beta of 1.39. Intuitive Surgical has a 1 year low of $254.85 and a 1 year high of $456.81. The firm’s 50-day moving average is $422.05 and its 200 day moving average is $394.72.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.40% and a net margin of 27.65%. The company’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 earnings per share. On average, equities analysts expect that Intuitive Surgical will post 4.8 EPS for the current fiscal year.

Insider Activity

In related news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total value of $1,971,169.88. Following the completion of the transaction, the executive vice president now directly owns 298 shares of the company’s stock, valued at $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. Insiders sold a total of 17,956 shares of company stock worth $6,927,011 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Baystate Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares during the last quarter. Creekmur Asset Management LLC raised its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the period. MCF Advisors LLC raised its position in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the period. Able Wealth Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Finally, Delos Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.